Abstract 1900: HSP 70 may cause EGFR-TKIs-resistance due to inhibit drug binding to EGFR in the cells that expressed mutant EGFR
Ohmori, Tohru, Kadofuku, Tsuyoki, Ichihashi, Yoko, Yamaoka, Toshimitsu, Hirose, Takashi, Adachi, Mitsuru, Saijo, Nagahiro
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Get full text
Journal Article
Abstract 5648: The characteristics of an acquired dual resistance to EGFR & MET inhibitors in non-small cell lung cancer, harboring active mutation of EGFR
Yamaoka, Toshimitsu, Ichihashi, Yoko, Murata, Yasunori, Oki, Yasunari, Sugiyama, Tomohide, Ishida, Hiroo, Shirai, Takao, Nakashima, Masanao, Okuda, Kentaro, Hirose, Takashi, Ohnishi, Tsukasa, Ohmori, Tohru
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article
Abstract 699: HSP70 specifically binds to 15 bp deletion mutant EGFR and modulates sensitivity to EGFR-TKI
Kadofuku, Tsuyoki, Kanome, Tomoko, Ichihashi, Yoko, Yamaoka, Toshimitsu, Hirose, Takashi, Adachi, Mitsuru, Saijo, Nagahiro, Ohmori, Tohru
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Get full text
Journal Article